Empowered Patient Podcast

Usama Malik, Chief Financial Officer and Chief Business Officer, Immunomedics discusses the challenges of developing effective medicines for people with triple negative breast cancer as well as Immunomedics' development of antibody-drug conjugates, directed therapies which have potential to provide new options for those with hard to treat cancers.

@immunomedicsinc

#breastcancer #TNBC #HER2 #TripleNegative #bladdercancer #urothelial

Immunomedics.com

Listen to the podcast here

Usama Malik, Chief Financial Officer and Chief Business Officer, Immunomedics discusses the challenges of developing effective medicines for people with triple negative breast cancer as well as Immunomedics' development of antibody-drug conjugates, directed therapies which have potential to provide new options for those with hard to treat cancers.

@immunomedicsinc

#breastcancer #TNBC #HER2 #TripleNegative #bladdercancer #urothelial

Immunomedics.com

Download the transcript here

Dr. Asher Nathan, CEO of NeoTX talks about the company's work developing immunotherapies for a wide range of solid tumors using their proprietary Selective T Cell Redirection (STR) platform. This technology enables therapies that bind a genetically engineered super antigen to the tumor surface which trigger a native, controlled immune response that can kill the cancer with potentially fewer side effects than currently available therapies. Asher discusses the company's lead STR molecule, NAP, which is being developed to treat advanced cancers. NAP, which has potential as both a monotherapy and in combination with checkpoint inhibitors, is currently in a Phase 1B clinical trial in collaboration with AstraZeneca.

#immunotherapy #immunotherapies #AntiCancer #SolidTumors #Tcell #Antigen #Cancer #Monotherapy #Checkpointinhibitors #Immunomodulators

NeoTX.com

Listen to the podcast here

Dr. Asher Nathan, CEO of NeoTX talks about the company's work developing immunotherapies for a wide range of solid tumors using their proprietary Selective T Cell Redirection (STR) platform. This technology enables therapies that bind a genetically engineered super antigen to the tumor surface which trigger a native, controlled immune response that can kill the cancer with potentially fewer side effects than currently available therapies. Asher discusses the company's lead STR molecule, NAP, which is being developed to treat advanced cancers. NAP, which has potential as both a monotherapy and in combination with checkpoint inhibitors, is currently in a Phase 1B clinical trial in collaboration with AstraZeneca.

#immunotherapy #immunotherapies #AntiCancer #SolidTumors #Tcell #Antigen #Cancer #Monotherapy #Checkpointinhibitors #Immunomodulators

NeoTX.com

Download the transcript here

Dr. Nader Pourhassan, is Director, President, and CEO, CytoDyn, a late-stage biotechnology company developing leronlimab (PRO 140), a targeted therapy with the potential to treat multiple diseases. Nader highlights CytoDyn's ongoing clinical trial evaluating leronlimab for metastatic triple negative breast cancer (mTNBC) and the company's plans to submit a Biologics License Agreement (BLA) to the U.S. Food and Drug Administration (FDA) for leronlimab in combination with highly active antiretroviral therapy (HAART) to treat patients suffering from HIV.

@CytoDyn

#HIV #mTNBC #TNBC #Leronlimab

CytoDyn.com

Listen to the podcast here

Dr. Nader Pourhassan, is Director, President, and CEO, CytoDyn, a late-stage biotechnology company developing leronlimab (PRO 140), a targeted therapy with the potential to treat multiple diseases. Nader highlights CytoDyn's ongoing clinical trial evaluating leronlimab for metastatic triple negative breast cancer (mTNBC) and the company's plans to submit a Biologics License Agreement (BLA) to the U.S. Food and Drug Administration (FDA) for leronlimab in combination with highly active antiretroviral therapy (HAART) to treat patients suffering from HIV.

@CytoDyn

#HIV #mTNBC #TNBC #Leronlimab

CytoDyn.com

Download the transcript here

Janet Lee is a patient advocate for those suffering from Congenital Rubella Syndrome (CRS) and is on a mission to educate healthcare professionals, patients, and caregivers about the delayed manifestations of this disease. This is also a story about a mother who was not vaccinated for Rubella and who gave birth to Janet who was born with extreme hearing loss and suffers from other complications from CRS. Thanks to her mother's intensive training and love, Janet learned to read lips was able to communicate with me on Skype to allow us to record this podcast.

Search on Facebook for CRS (Congenital Rubella Syndrome) for an invitation to join Janet's private group.

Listen to the podcast here

Janet Lee is a patient advocate for those suffering from Congenital Rubella Syndrome (CRS) and is on a mission to educate healthcare professionals, patients, and caregivers about the delayed manifestations of this disease. This is also a story about a mother who was not vaccinated for Rubella and who gave birth to Janet who was born with extreme hearing loss and suffers from other complications from CRS. Thanks to her mother's intensive training and love, Janet learned to read lips was able to communicate with me on Skype to allow us to record this podcast.

Search on Facebook for CRS (Congenital Rubella Syndrome) for an invitation to join Janet's private group.

Read the transcript here

Dr. Rob Mordkin is Chief Medical Officer for LetsGetChecked.com and Chief of Urology at the Virginia Hospital Center. We talk about his strong belief in giving individuals access to in-home health testing to allow them to check on warning signs, confirm findings of other lab tests, and provide on-going monitoring of chronic conditions. With or without a primary care doctor, patients can order tests, have results reviewed by a physician, discuss findings with a nurse, and if necessary, receive a prescription.

@LetsGetChecked

LetsGetChecked.com

Listen to the podcast here

Dr. Rob Mordkin is Chief Medical Officer for LetsGetChecked.com and Chief of Urology at the Virginia Hospital Center. We talk about his strong belief in giving individuals access to in-home health testing to allow them to check on warning signs, confirm findings of other lab tests, and provide on-going monitoring of chronic conditions. With or without a primary care doctor, patients can order tests, have results reviewed by a physician, discuss findings with a nurse, and if necessary, receive a prescription.

@LetsGetChecked

LetsGetChecked.com

Read the transcript here